首页> 外国专利> INDUCTION OF T CELL TOLERANCE USING A SOLUBLE MOLECULE THAT CAN SIMULTANEOUSLY BLOCK TWO COSTIMULATORY PATHWAYS

INDUCTION OF T CELL TOLERANCE USING A SOLUBLE MOLECULE THAT CAN SIMULTANEOUSLY BLOCK TWO COSTIMULATORY PATHWAYS

机译:使用可同时阻止两种刺激性途径的可溶分子诱导T细胞耐受

摘要

The invention provides a ligand capable of binding to the human CD40 antigen and to the human CD86 antigen, and optionally to the CD80 antigen, said antigens being located on the surface of human lymphocytes, as well as vectors capable of producing the ligand and uses of the ligand in inducing T cell tolerance. Said ligand can be an antibody, which can be a trispecific diabody capable of binding to CD40 and to both CD80 and CD86, or a bispecific diabody capable of binding to human CD40 and to human CD86, or else a trispecific triabody capable of binding to CD40, CD80 and CD86.
机译:本发明提供了能够与人CD40抗原和人CD86抗原以及任选地与CD80抗原结合的配体,所述抗原位于人淋巴细胞的表面上,以及能够产生该配体的载体及其用途配体诱导T细胞耐受性。所述配体可以是抗体,其可以是能够与CD40以及CD80和CD86两者结合的三特异性双抗体,或者能够与人CD40和人CD86结合的双特异性双抗体,或者能够与CD40结合的三特异性三抗体。 ,CD80和CD86。

著录项

  • 公开/公告号EP0922111A1

    专利类型

  • 公开/公告日1999-06-16

    原文格式PDF

  • 申请/专利权人 TANOX PHARMA B.V.;

    申请/专利号EP19970930902

  • 发明设计人 DE BOER MARK;

    申请日1997-07-23

  • 分类号C12N15/86;C07K16/46;C07K19/00;C12N5/10;A61K39/395;

  • 国家 EP

  • 入库时间 2022-08-22 02:18:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号